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Abstract
Background: Predicting response to cardiac resynchronization therapy (CRT) remains a challenge. We evaluated
the role of baseline QRS pattern to predict response in terms of improvement in biventricular ejection fraction (EF).
Methods: Consecutive patients (pts) undergoing CRT implantation underwent radionuclide angiography at
baseline and at mid-term follow-up. The relationship between baseline QRS pattern and mechanical dyssynchrony
using phase analysis was evaluated. Changes in left and right ventricular EF (LVEF and RVEF) were analyzed with
regard to baseline QRS pattern.
Results: We enrolled 56 pts, 32 with left bundle branch block (LBBB), 4 with right bundle branch block (RBBB) and
20 with non-specific intraventricular conduction disturbance (IVCD). A total of 48 pts completed follow-up. LBBB pts
had significantly greater improvement in LVEF compared to RBBB or non-specific IVCD pts (+9.6 ± 10.9% vs. +2.6 ±
7.6%, p = 0.003). Response (defined as ≥ 5% increase in LVEF) was observed in 68% of LBBB vs. 24% of non-specific
IVCD pts (p = 0.006). None of the RBBB pts were responders. RVEF was significantly improved in LBBB (+5.0 ± 9.0%,
p = 0.007), but not in non-specific IVCD and RBBB pts (+0.4 ± 5.8%, p = 0.76). At multivariate analysis, LBBB was the
only predictor of LVEF response (OR, 7.45; 95% CI 1.80-30.94; p = 0.006), but not QRS duration or extent of
mechanical dyssynchrony.
Conclusions: Presence of a LBBB is a marker of a positive response to CRT in terms of biventricular improvement.
Pts with non-LBBB pattern show significantly less benefit from CRT than those with LBBB.
Keywords: Cardiac resynchronization therapy, Left ventricular ejection fraction, Right ventricular ejection fraction,
Dyssynchrony, Nuclear angiography, QRS morphology
Background
Cardiac resynchronization therapy (CRT) reduces mor-
bidity and mortality in patients (pts) with congestive
heart failure [1-5] improving clinical status [1-3] and
favoring ventricular reverse remodeling [2,5-7]. However
clinical and/or echocardiographic response is present in
only 50-70% of CRT pts [3,8], suggesting that the link
between standard criteria for CRT and expected
response is often weak. Several parameters of electrical
and mechanical dyssynchrony have been proposed to
improve pt selection, even though QRS duration is cur-
rently the only recommended parameter [9,10]. In CRT
pts a baseline left bundle branch block (LBBB) has been
demonstrated to be associated with a more favorable
prognosis in terms of freedom from death or major car-
diovascular events, and with a more left ventricular (LV)
reverse remodeling compared to a baseline right bundle
branch block (RBBB) [11,12]. Likewise in the RAFT trial
[13] LBBB pts showed more benefit from CRT in terms
of death or hospitalization for heart failure compared to
pts with RBBB, non-specific intraventricular conduction
disturbance (IVCD) or paced QRS at baseline. Further-
more, in a secondary analysis of the MADIT-CRT trial
[14] a significant reduction in the risk of heart failure or
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death has been reported in LBBB pts within the CRT
plus defibrillator (CRT-D) group. However, if the role of
baseline LBBB in terms of prognosis and LV function
during CRT seems to be established, there is lack of
data regarding its effects on right ventricular (RV) func-
tion. Likewise, few data are available on the impact of
baseline RBBB or non-specific IVCD patterns on biven-
tricular function during CRT.
In our study we investigated the relationship between
baseline QRS pattern and biventricular mechanical dys-
synchrony and we evaluated the role of baseline QRS
morphology to predict CRT response in terms of
improvement in biventricular ejection fraction (EF).
Radionuclide angiography with phase analysis was used
to evaluate mechanical dyssynchrony and to measure
LVEF and RVEF.
Methods
Patient population
We enrolled 28 pts undergoing CRT device implanta-
tion at the Cardiology Institute, University Hospital of
Bologna (inclusion period: January 2007- July 2009), and
28 pts implanted at the Cardiology Service, University
Hospital of Geneva (inclusion period: September 2002-
December 2004). According to current guidelines [9],
pts had to be in New York Heart Association (NYHA)
class III or IV, with LVEF ≤ 35% and with QRS duration
≥ 120 ms. All pts were in sinus rhythm at implantation
and under optimal pharmacological treatment.
A control group of 25 subjects without cardiovascular
disease and with normal electrocardiogram (ECG),
matched for age and sex with the study group, was eval-
uated to define the cut-off of inter and intraventricular
dyssynchrony of phase analysis parameters.
The local institutional Ethics Committees (Ethics
Committee of the S.Orsola-Malpighi Hospital of Bologna
and Clinical Ethics Committee of the Geneva University
Hospitals) approved the study protocol, and all patients
provided a written informed consent for participation.
Device implantation
All device leads were placed transvenously. The RV lead
was positioned at the mid-septum or at the apex at the
discretion of the implanting physician. The LV lead was
positioned via the coronary sinus, targetting lateral or
posterolateral veins. An echocardiographic-guided opti-
mization of CRT programming was performed after
implantation according to conventional clinical practice.
Baseline electrocardiograms
A surface 12-lead ECG was recorded before implanta-
tion at speed of 25 mm/s and at 10 mm/mV gain. The
QRS interval was measured from its first deflection to
its end at the widest QRS complex. The QRS patterns
were classified as LBBB or RBBB or non-specific IVCD
according to the “AHA/ACCF/HRS Recommendations
for the Standardization and Interpretation of the Elec-
trocardiogram” [15]. Left axis deviation was defined as a
QRS axis leftward of -30° [15].
Radionuclide angiography
LVEF and RVEF were measured by radionuclide angio-
graphy at baseline, during spontaneous rhythm, and at
mid-term follow-up (between 3 and 6 month from
device implantation), during biventricular pacing. The
response to CRT was defined by an increase in LVEF of
≥ 5% at follow-up end [16]. Radionuclide angiography
was performed as previously described [17,18], using a
gamma camera Prism 2000 XP- Philips in Bologna and
a gamma camera ADAC-Philips in Geneva. A blood
sample was drawn to label red blood cells with 1 GBq
of 99mTechnetium. The ECG was monitored continu-
ously for R-wave gating, with elimination of extrasystolic
and post-extrasystolic cycles. Multigated equilibrium
blood pool planar scintigrams at 32 frames/cycle (200-
250 Kcounts/frame in a 128 × 128 matrix) were
acquired until the number of counts was at least 6 ×
106 in the “best septal separation” left anterior oblique
view that provided optimal RV and LV discrimination.
A background-corrected, time-activity curve was con-
structed by a semi-automated edge-detection method
with a variable region of interest, verified visually and
modified manually if necessary. LVEF and RVEF were
computed on the basis of relative end-diastolic and end-
systolic counts.
Inter- and intraventricular dyssynchrony were
obtained by phase analysis, as previously reported [19].
The images acquired for measuring LVEF and RVEF
were digitally processed to display the “phase” of each
pixel overlying the ECG-gated equilibrium blood pool.
The computer assigned a phase angle (between 0 and
360°) to each pixel of the image. A phase histogram was
constructed, corresponding to the sequence of ventricu-
lar contraction during the cardiac cycle, with color
codes corresponding to different regions of the ventri-
cles. Each ventricle was analyzed separately, with calcu-
lation of the mean and standard deviation (SD) of the
phase histogram. Interventricular delay was assessed by
the absolute difference between the mean phase angles
of each ventricle, whereas intraventricular delay was
represented by the SD of the phase histogram for that
ventricle. Both inter and intraventricular delays were
expressed in angles (°).
Statistical analysis
Statistical analyses were performed using SPSS software
(SPSS Inc., Chicago, IL, USA). Continuous variables
showing normal distribution according to Kolmogorov-
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Smirnov test were compared using paired and unpaired
Student’s t-tests for related and unrelated groups,
respectively. Data showing non-Gaussian distribution
were processed using the Mann-Whitney test. Correla-
tions between quantitative variables were examined
using Pearson’s test. Fisher’s exact test was used for
evaluating categorical variables. Logistic regression ana-
lysis was performed to evaluate the relationship between
baseline clinical parameters and CRT response. Values
were expressed as mean ± SD or median and interquar-
tile range (IQR) in case of non-Gaussian distribution.
Odds ratios (OR) were presented with 95% confidence
intervals (CIs). A P-value of less than 0.05 was consid-
ered statistically significant.
Results
We enrolled a total of 56 pts, 42 males, age 66 ± 11
years (see Table 1). Thirty-four pts received a CRT-D
device. LV lead position was lateral/posterolateral in 49
pts (88%) and anterolateral in 7 pts (12%); RV lead was
positioned at the mid-septum in 11 pts (20%). There
were no significant differences between groups as
regards the position of LV and RV leads. A total of 48
pts completed follow-up after a median of 5.5 (3.5-7.1)
months. Two pts (1 LBBB and 1 RBBB) died for non-
cardiac causes and 6 pts dropped out (3 LBBB and 3
non-specific IVCD).
Baseline QRS pattern and mechanical dyssynchrony
In the control group (age 63 ± 4 years, 13 males, LVEF
62 ± 6%, RVEF 48 ± 5%), intraventricular delay for the
left ventricle was 10.9° (8.2-16.1°) and 16.9° (12.3-19.6°)
for the right ventricle. The interventricular delay was
5.0° (3.0-11.5°). Values greater than the 95th percentile
of the distribution curve (after rounding to a multiple of
5°) were considered as dyssynchronous. Therefore, we
defined intraventricular dyssynchrony as SD values > 20°
for the LV phase and as SD values > 25° for the RV
phase. Interventricular dyssynchrony was defined as
values > 15°.
Table 2 shows the baseline clinical characteristics of
the study population according to QRS pattern. The
QRS duration was significantly longer in the LBBB
group compared to the non-specific IVCD group.
Furthermore, non-ischemic aetiology of heart failure was
prevalent in the LBBB pts and male sex was more repre-
sented in the non-specific IVCD group.
The comparisons of mechanical dyssynchrony accord-
ing to QRS pattern and QRS duration are shown in
Table 3. The differences in dyssynchrony between the
groups did not reach statistical significance, although
Table 1 Demographics of the patient population
Patient demographics (n = 56)
Age (years) 66 ± 11
Males 42 (75%)
Aetiology of heart failure
Ischaemic 22 (39%)
Non-ischaemic 34 (61%)
NYHA class
III 49 (88%)
IV 7 (12%)
Paroxysmal AF 5 (9%)
Hypertension 30 (54%)
Diabetes 19 (34%)
Chronic kidney disease 14 (25%)
QRS morphology
LBBB 32 (57%)
RBBB 4 (7%)
Non-specific IVCD 20 (36%)
QRS duration (ms) 140 (120-160)
QRS ≥ 150 ms 27 (48%)
LVEF (%) 22 ± 6
RVEF (%) 36 ± 10
Traitement
ACE-I/ARBs 52 (93%)
Beta-blockers 39 (70%)
Diuretics 50 (89%)
NYHA class, New York Heart Association class; AF, atrial fibrillation; LBBB, left
bundle branch block; RBBB, right bundle branch block; IVCD, intraventricular
conduction disturbance; LVEF, left ventricular ejection fraction; RVEF, right
ventricular ejection fraction; ACE-Is, angiotensin-converting enzyme inhibitors;
ARBs, angiotensin II receptor blockers
Table 2 Baseline characteristics according to QRS pattern
LBBB
(n = 32)
RBBB
(n = 4)
Non-specific
IVCD
(n = 20)
Age (years) 66 ± 11 65 ± 9 67 ± 10
Males 21 (66%) 2 (50%) 19 (95%)*
Aetiology of heart
failure
Ischaemic 9 (28%) 3 (75%) 10 (50%)
Non-ischaemic 23 (72%) 1 (25%) 10 (50%)
NYHA class
III 28 (88%) 4 (100%) 17 (85%)
IV 4 (12%) 0 (0%) 3 (15%)
QRS duration (ms) 160 (140-
180)
140 (125-
170)
120 (120-130)§
QRS ≥ 150 ms 22 (69%) 1 (25%) 4 (20%)†
LEFT axis 15 (47%) 3 (75%) 10 (50%)
LVEF (%) 23 ± 6 25 ± 6 21 ± 7
RVEF (%) 37 ± 11 38 ± 9 34 ± 8
*p = 0.018 vs LBBB; §p < 0.001 vs LBBB; †p = 0.001 vs LBBB
LBBB, left bundle branch block; RBBB, right bundle branch block; IVCD,
intraventricular conduction disturbance; NYHA class, New York Heart
Association class; LVEF, left ventricular ejection fraction; RVEF, right ventricular
ejection fraction
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comparisons are limited by small sample size and data
dispersion.
Baseline QRS pattern and changes in biventricular
ejection fraction at follow-up
CRT response was observed in 68% of LBBB vs. 24% of
non-specific IVCD pts (p = 0.006). None of the RBBB
pts were responders. Pts with LBBB had significantly
greater improvement in LVEF compared to those with
RBBB and non-specific IVCD (+9.6 ± 10.9% vs. +2.6 ±
7.6%, p = 0.003) (see Figure 1). RVEF was significantly
improved in LBBB pts (+5.0 ± 9.0%, p = 0.007), but not
in non-specific IVCD and RBBB pts (+0.4 ± 5.8%, p =
0.76) (see Figure 2). No significant correlation was
found between increase in LVEF and increase in RVEF
in LBBB pts (r = 0.22, p = 0.25).
Reproducibility of radionuclide angiography
LVEF and RVEF and LV and RV mean phase angle
reproducibility were assessed in independent readings,
done by the same operator, of the same nuclear
examination.
We found that the difference between two indepen-
dent measurements, expressed in absolute terms, was
0.49 ± 2.47% (centre A) and 0.56 ± 1.58% (centre B) for
LVEF; 0.10 ± 3.5% (centre A) and 0.65 ± 6.1% (center
B) for RVEF; 2.20 ± 8.84° (centre A) and 3.39 ± 4.63°
(centre B) for LV mean phase angle; 2.01 ± 7.31° (centre
A) and 2.28 ± 9.91° (centre B) for RV mean phase angle.
These data indicate that the differences between two
independent measurements of RVEF or LVEF or mean
phase angles were negligible in absolute terms. Further-
more no significant differences were found between the
two centres.
Baseline clinical characteristics predicting response to
CRT
Baseline LBBB showed a significantly higher prevalence
in CRT responders compared to RBBB and non-specific
IVCD (p = 0.001) (see Table 4). Furthermore, CRT
responders tended to have greater QRS duration and
also tended to have more frequently cardiomyopathy of
non-ischemic origin, though significant differences were
not present. Finally, mechanical dyssynchrony
Table 3 Comparison of mechanical dyssynchrony according to QRS pattern and QRS duration
Control group LBBB RBBB Non-specific IVCD QRS < 150 ms QRS ≥ 150 ms
(n = 25) (n = 32) (n = 4) (n = 20) (n = 29) (n = 27)
SD of LV mean phase (°) 10.9 (8.2-16.1) 42.3 (24.7-77.9)* 35.4 (28.8-39.2)* 43.4 (36.0-59.6)* 36.9 (27.0-50.4)* 48.4 (29.5-78.1)*
SD of RV mean phase (°) 16.9 (12.3-19.6) 27.2 (18.8-38.8)* 20.4 (11.9-34.9) 25.5 (17.8-36.0)* 26.1 (18.8-35.9)* 25.5 (17.4-39.8)*
Interventricular delay (°) 5.0 (3.0-11.5) 21.0 (8.5-34.8)* 17.5 (4.0-40.0) 14.0 (6.5-25.3)* 19.0 (6.5-28.0)* 21.0 (8.0-28.0)*
Intra LV dyssynchrony 28 (88%) 4 (100%) 20 (100%) 26 (90%) 25 (93%)
Intra RV dyssynchrony 18 (56%) 2 (50%) 10 (50%) 16 (55%) 14 (52%)
Interventricular dyssynchrony 22 (69%) 2 (50%) 10 (50%) 16 (55%) 17 (63%)
*p < 0.01 vs control group
LBBB, left bundle branch block; RBBB, right bundle branch block; IVCD, intraventricular conduction disturbance; SD, standard deviation; LV, left ventricular; RV,
right ventricular
Figure 1 Baseline QRS pattern and changes in left ventricular ejection fraction (LVEF) at follow-up. LBBB, left bundle branch block; RBBB,
right bundle branch block; NSCD, non-specific intraventricular conduction disturbance.
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parameters did not differ significantly between the two
groups. At multivariate analysis, LBBB was the only pre-
dictor of CRT response (OR, 7.45; 95% CI 1.80-30.94; p
= 0.006) (see Table 5).
Discussion
The main findings of our study may be summarized as
follows: 1. A baseline LBBB morphology is a marker of a
positive response to CRT in terms of improvement not
only in LVEF but also in RVEF; 2. Pts with a baseline
RBBB or an IVCD pattern seem to derive less benefit
from CRT compared to those with LBBB.
Our study included pts with both non-ischemic as
well as ischemic cardiomyopathy and assessed the
response to CRT in terms of both right and left ventri-
cular function. In the literature limited attention has
been paid to RV function, and this can be easily
explained by the limitation of echocardiographic
approaches. In pts with idiopathic dilated cardiomyopa-
thy, Fauchier et al. [20] demonstrated a relationship
between QRS morphology and inter- and intraventricu-
lar delays at phase analysis. In particular, a high intra-
LV dyssynchrony was associated with LBBB and left axis
deviation. In our study, despite the lack of correlation
between QRS morphology and degree of mechanical
dyssynchrony, LBBB pts showed a significant improve-
ment in biventricular EF compared to RBBB and IVCD
pts. Fantoni et al. [21], using a three-dimensional non-
fluoroscopic electroanatomic contact mapping system,
documented a similar degree of LV activation delay in
LBBB and RBBB heart failure pts. However RBBB pts
presented also a delayed activation of anterior and lat-
eral RV regions, that was absent in pts with LBBB.
These data may suggest a more complex electromecha-
nical profile in heart failure RBBB pts, explaining a poor
response to CRT and reflecting at the same time the
need to identify specific selection criteria.
Figure 2 Baseline QRS pattern and changes in right ventricular ejection fraction (RVEF) at follow-up. LBBB, left bundle branch block;
RBBB, right bundle branch block; NSCD, non-specific intraventricular conduction disturbance.
Table 4 Baseline clinical characteristics according to CRT
response at follow-up
Responders
(n = 23)
Non
Responders
(n = 25)
p
Age (years) 67 ± 11 65 ± 11 0.64
Males 15 (65%) 21 (84%) 0.19
Aetiology of heart failure
Ischaemic 6 (26%) 11 (44%) 0.24
Non-ischaemic 17 (74%) 14 (56%)
NYHA class
III 21 (87%) 23 (92%) 0.67
IV 3 (13%) 2 (8%)
QRS duration (ms) 150 (120-160) 140 (120-180) 0.77
QRS ≥ 150 ms 12 (52%) 12 (48%) >
0.99
LEFT axis 11 (48%) 14 (56%) 0.77
QRS morphology
LBBB 19 (83%) 9 (36%) 0.001*
RBBB 0 (0%) 3 (12%) 0.24§
Non-specific IVCD 4 (17%) 13 (52%) 0.017†
LVEF (%) 23 ± 5 20 ± 6 0.05
RVEF (%) 37 ± 8 36 ± 10 0.74
SD of LV mean phase (°) 43.0 (24.0-
73.0)
43.0 (35.5-64.5) 0.48
SD of RV mean phase (°) 28.0 (19.0-
40.0)
26.0 (17.5-36.5) 0.40
Interventricular delay (°) 21.0 (8.0-38.0) 20.0 (8.5-27.5) 0.56
Intra LV dyssynchrony 20 (87%) 24 (96%) 0.34
Intra RV dyssynchrony 16 (70%) 13 (52%) 0.25
Interventricular
dyssynchrony
16 (70%) 15 (60%) 0.56
*LBBB vs. RBBB and non-specific IVCD; §RBBB vs. LBBB and non-specific IVCD;
† non-specific IVCD vs. LBBB and RBBB.
NYHA class, New York Heart Association class; LBBB, left bundle branch block;
RBBB, right bundle branch block; IVCD, intraventricular conduction
disturbance; LVEF, left ventricular ejection fraction; RVEF, right ventricular
ejection fraction; SD, standard deviation; LV, left ventricular; RV, right
ventricular
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Unfortunately, the prevalence of RBBB and non-spe-
cific IVCD is very low in the major CRT randomized
trials (about 10% for RBBB) [4,22], therefore the avail-
able data for these groups of pts are limited. In the
analysis of pooled data from the MIRACLE and Con-
tak CD trials [23] the LVEF or maximal oxygen con-
sumption did not improve significantly at 6 months
follow-up in RBBB pts randomly assigned to CRT.
Aldestein et al. [12] evaluated 636 consecutive pts
undergoing to CRT implantation with LBBB, RBBB, or
paced QRS at baseline. RBBB pts had low rates of
symptomatic and echocardiographic response and the
survival free from orthotopic heart transplantation or
ventricular assist device placement was significantly
worse compared to LBBB pts. In another study of
Rickard et al. [24] pts with RBBB and non specific-
IVCD had less reverse remodeling and symptomatic
benefit from CRT compared with those with a native
LBBB. Likewise in the CRT-D arm of the MADIT-
CRT trial [25] LBBB pts showed a significantly higher
reduction in LV volumes and a significant increase in
LVEF compared to non-LBBB pts. Our study is in
agreement with these results. Furthermore, we demon-
strated that LBBB pts also had a significant improve-
ment in RVEF (although the magnitude of the
response was less than for LVEF), whereas pts with
non-LBBB had no significant improvement in RVEF.
The mechanisms by which LBBB pattern promotes
improvement in RVEF in response to CRT are unclear
[26], but may result in part from a reduction in right
ventricular afterload with improvement in left-sided
pump function.
Study limitations
The small RBBB sample size was the main limitation of
our study, reducing the statistical value of results for
this specific group of pts. However, as previously
reported, the low prevalence of RBBB candidates to
CRT reflects a common condition encountered in clini-
cal practice as well as in most trials during pts selection
for CRT. In this context, further prospective studies are
needed to investigate the relationship between electro-
mechanical dyssynchrony and CRT response in RBBB
pts in order to improve pts selection and optimize the
device system capabilities in these pts.
Conclusion
In this prospective study we evaluated the relationship
between QRS pattern, mechanical dyssynchrony and
CRT response. LBBB is a significant marker of a positive
response to CRT, irrespective of QRS duration, in terms
of improvement not only in LVEF but also in RVEF. Pts
with non-LBBB pattern seem to benefit less from CRT
than those with LBBB. Further evaluations to clarify the
mechanisms allowing RVEF improvement in LBBB pts
are required.
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